Diagnosis, treatment, and prevention of cardiovascular toxicity related to anti-cancer treatment in clinical practice: an opinion paper from the working group on cardio-oncology of the Korean society of echocardiography

Hyungseop Kim, Woo Baek Chung, Kyoung Im Cho, Bong Joon Kim, Jeong Sook Seo, Seong Mi Park, Hak Jin Kim, Ju Hee Lee, Eun Kyoung Kim, Ho Joong Youn

    Research output: Contribution to journalReview articlepeer-review

    14 Citations (Scopus)

    Abstract

    Cardiovascular (CV) toxicity associated with anti-cancer treatment is commonly encountered and raises critical problems that often result in serious morbidity or mortality. Most cardiac toxicities are related to the cumulative dose of chemotherapy; however, the type of chemotherapy, concomitant agents, and/or conventional CV risk factors have been frequently implicated in CV toxicity. Approximately half of the patients exhibiting CV toxicity receive an anthracycline-based regimen. Therefore, serologic biomarkers or cardiac imagings are important during anti-cancer treatment for early detection and the decision of appropriate management of cardiotoxicity. However, given the difficulty in determining a causal relationship, a multidisciplinary collaborative approach between cardiologists and oncologists is required. In this review, we summarize the CV toxicity and focus on the role of cardiac imaging in management strategies for cardiotoxicity associated with anti-cancer treatment.

    Original languageEnglish
    Pages (from-to)1-25
    Number of pages25
    JournalJournal of Cardiovascular Ultrasound
    Volume26
    Issue number1
    DOIs
    Publication statusPublished - 2018

    Keywords

    • Anti-cancer treatment
    • Cardio-oncology
    • Cardiovascular toxicity
    • Echocardiography

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging
    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Diagnosis, treatment, and prevention of cardiovascular toxicity related to anti-cancer treatment in clinical practice: an opinion paper from the working group on cardio-oncology of the Korean society of echocardiography'. Together they form a unique fingerprint.

    Cite this